0.00Open0.35Pre Close0 Volume1 Open Interest10.00Strike Price0.00Turnover0.00%IV436.27%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-3DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.51Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Omega Therapeutics Stock Discussion
NEWS
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $S&P 500 Index(.SPX.US)$ rose 0.2% to close at 4,697.24 Friday, while the $Nasdaq Composite Index(.IXIC.US)$ rose less...
Omega shares almost doubled Thursday after the company said its flagship’s Pioneering Medicines initiative, and Novo Nordisk will jointly advance an obesity management program through preclinical development and...
No comment yet